IP Verse

The Medicines Company Uk Limited opposition analysis

COMPANY ANALYSIS

Patent Number:

Title:

Further Novel Forms Of Interfering Rna Molecules

Applicant:

Opposition Date:

Oct 16, 2018

Patent Number:

Title:

Futher Novel Forms Of Interfering Rna Molecules

Applicant:

Opposition Date:

Dec 14, 2017

Patent Number	Title	Applicant	Opposition Date
EP1857547	Further Novel Forms Of Interfering Rna Molecules	ATUGEN AG	Oct 16, 2018
EP2258847	Futher Novel Forms Of Interfering Rna Molecules	SILENCE THERAPEUTICS AG	Dec 14, 2017

SILENCE THERAPEUTICS GMBH

ATUGEN AG

SILENCE THERAPEUTICS AG

Feel free to send us a message here and we will get back to you